Connect with us

AI Research

Causaly Introduces First Agentic AI Platform Built for Life Sciences Research and Development

Published

on


Specialized AI agents automate research workflows and accelerate
drug discovery and development with transparent, evidence-backed insights

LONDON, Sept. 16, 2025 /PRNewswire/ — Causaly today introduced Causaly Agentic Research, an agentic AI breakthrough that delivers the transparency and scientific rigor that life sciences research and development demands. First-of-their-kind, specialized AI agents access, analyze, and synthesize comprehensive internal and external biomedical knowledge and competitive intelligence. Scientists can now automate complex tasks and workflows to scale R&D operations, discover novel insights, and drive faster decisions with confidence, precision, and clarity.

Industry-specific scientific AI agents

Causaly Agentic Research builds on Causaly Deep Research with a conversational interface that lets users interact directly with Causaly AI research agents. Unlike legacy literature review tools and general-purpose AI tools, Causaly Agentic Research uses industry-specific AI agents built for life sciences R&D and securely combines internal and external data to create a single source of truth for research. Causaly AI agents complete multi-step tasks across drug discovery and development, from generating and testing hypotheses to producing structured, transparent results always backed by evidence.

“Agentic AI fundamentally changes how life sciences conducts research,” said Yiannis Kiachopoulos, co-founder and CEO of Causaly. “Causaly Agentic Research emulates the scientific process, automatically analyzing data, finding biological relationships, and reasoning through problems. AI agents work like digital assistants, eliminating manual tasks and dependencies on other teams, so scientists can access more diverse evidence sources, de-risk decision-making, and focus on higher-value work.”

Solving critical research challenges

Research and development teams need access to vast amounts of biomedical data, but manual and siloed processes slow research and create long cycle times for getting treatments to market. Scientists spend weeks analyzing narrow slices of data while critical insights remain hidden. Human biases influence decisions, and the volume of scientific information overwhelms traditional research approaches.

Causaly addresses these challenges as the first agentic AI platform for scientists that combines extensive biomedical information with competitive intelligence and proprietary datasets. With a single, intelligent interface for scientific discovery that fits within scientists’ existing workflows, research and development teams can eliminate silos, improve productivity, and accelerate scientific ideas to market.

Comprehensive agentic AI research platform

As part of the Causaly platform, Causaly Agentic Research provides scientists multiple AI agents that collaborate to:

  • Conduct complex analysis and provide answers that move research forward
  • Verify quality and accuracy to dramatically reduce time-to-discovery
  • Continuously scan the scientific landscape to surface critical signals and emerging evidence in real time
  • Deliver fully traceable insights that help teams make confident, evidence-backed decisions while maintaining scientific rigor for regulatory approval
  • Connect seamlessly with internal systems, public applications, data sources, and even other AI agents, unifying scientific discovery

Availability

Causaly Agentic Research will be available in October 2025, with a conversational interface and foundational AI agents to accelerate drug discovery and development. Additional specialized AI agents are planned for availability by the end of the year.

Explore how Causaly Agentic Research can redefine your R&D workflows and bring the future of drug development to your organization at causaly.com/products/agentic-research.

About Causaly

Causaly is a leader in AI for the life sciences industry. Leading biopharmaceutical companies use the Causaly AI platform to find, visualize, and interpret biomedical knowledge and automate critical research workflows. To learn how Causaly is accelerating drug discovery through transformative AI technologies and getting critical treatments to patients faster, visit www.causaly.com.

Logo – https://mma.prnewswire.com/media/2653240/Causaly_Logo_Logo.jpg



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

AI Research

OpenAI reveals how most people are using ChatGPT | Science, Climate & Tech News

Published

on


Most people are using ChatGPT to ask questions and get advice, new data from OpenAI revealed.

Although AI bots can do anything from coding to drafting emails or even playing, around 49% of the requests sent to ChatGPT since November 2022 were people asking the bot questions and looking for information, a report by the National Bureau of Economic Research (NBER) and OpenAI found.

It’s the biggest study of its kind and draws from the huge amount of data collected by OpenAI – around 10% of the world’s population is now thought to use the AI tool.

Please use Chrome browser for a more accessible video player

Is AI a bubble waiting to burst?

Although there was a steady growth in people using ChatGPT for work-related queries, more than 70% of all usage was non-work related, according to the report.

There’s also been a shift in who is using AI tools.

Early adopters of AI tended to be men, with around 80% of weekly users having typically masculine first names in the months after ChatGPT was released.

By June 2025, however, users were more likely to have typically female first names, something the authors described as a “dramatic shift”.

More on Artificial Intelligence

Anthropic AI, which runs the Claude AI chatbot, also released its own data on how customers are using AI.

It found that the use of AI strongly correlated with average incomes.

More affluent nations like Singapore and Canada were at the top end of countries using AI, while emerging economies like Indonesia, India and Nigeria, used Claude less.

In the US, economic differences even played out at state level, and Claude researchers found that adoption of the technology rose faster with income.

Read more from Sky News:
PM’s ‘AI superpower’ dream at risk, industry warns
Zelenskyy makes demand of Trump
Trump sues New York Times

Each 1% increase in state GDP was associated with a 1.8% increase in usage of AI.

Usage also reflected what those areas were best known for; in California, Claude was often used to help with IT problems, in Florida, it was used for financial services and in Washington DC it was used for document editing and career assistance.

AI literacy consultant Sarah J Lundrigan posted about the two reports, saying the “blunt truth” is: “If you’re still treating AI as ‘something to try later,’ you’re behind.

“The value isn’t in futuristic features – it’s in solving today’s friction points.

“The winners will be the ones who can simplify adoption, reduce overwhelm, and make AI part of how people work and live.”



Source link

Continue Reading

AI Research

5 ways AI is shaping packaging today

Published

on


This audio is auto-generated. Please let us know if you have feedback.

In Nestlé’s R&D department, a tool is identifying entirely new kinds of high-barrier packaging materials. It’s generative AI

A growing number of consumer packaged goods companies are starting to deploy artificial intelligence in their packaging design processes. So too are packaging manufacturers exploring how the technology can save time and resources in design and manufacturing.

Nestlé’s researchers feed public and proprietary documents into a knowledge base. Then, they fine-tune the data using a transformer, together with IBM Research, to understand how molecular features in packaging correlate to physical properties. Finally, the AI-based model analyzes the inputs within the set parameters.

“It can identify appropriate materials that are suitable for protecting dry and sensitive foods such as coffee from moisture, temperature swings and oxygen,” a Nestlé spokesperson said via email.

While the use cases are nascent, AI is catching on. Last year, a McKinsey survey of more than 200 paper and packaging executives found that 95% said they believe their companies should invest in generative AI. And 77% said their firms have moderate to strong intentions to use gen AI in the near future. 

How packaging leaders and CPGs are using AI

Tom Egan, vice president of industry services for the Association for Packaging and Processing Technologies, or PMMI, sees “a pretty enthusiastic acceptance” of AI in the industry. He said applications range from logistics to sales and marketing to manufacturing. 

Here are some of the processes in which packaging companies and CPGs are starting to use AI.

New designs and prototypes

One of the notable potential benefits of AI — and among the biggest use cases being explored today — is the ability to assess packaging modifications or updates in a virtual environment.

When a client requests a new design from flexible packaging provider Tradepak, the company inputs the customer’s parameters into its systems, said President Rafael Recao. AI can rapidly pull from databases, synthesize data points, and deliver design and substrate recommendations. Then, packaging leaders make a final decision.

With simulation models and digital twins, AI can look at form factors, examine touch points and predict consumer reactions to quickly generate 10 mockups of a SKU’s packaging, Egan said, rather than physically making and testing each version. 

AI can “analyze this unbelievably large number of data points and provide you with insights,” Egan said, adding that packaging leaders can refine the options from there.

Simulation models can also help to design packaging for the same product in different channels, such as one version for retail shelves and another for e-commerce. AI could determine the best design and protective properties for each channel while ensuring brand consistency, Egan said.

Simulating testing

Colgate-Palmolive is exploring how simulations could validate new designs for components such as bottles, caps and spray pumps, said Sukhdev Singh Saini, global toothbrush and devices packaging lead at the company.

Without AI, “we have to physically make a lot of samples to test,” Saini said. Then, the samples have to be shipped, tested and possibly altered before being sent out for another round of testing. “There is a lot of time involved, a lot of material involved.”

With a simulation model, though, the CPG feeds specs into a system, and AI replicates testing to provide results. Saini acknowledged the tech is still a work in progress and not a 100% replacement just yet.

Jonathan Garini, CEO and enterprise AI consultant at Fifthelement, sees brands using algorithms to simulate how a substrate performs in real-life conditions like humidity or rough handling.

“This not only accelerates the test cycle but also can lower the cost of physical prototyping significantly,” Garini said.

Packaging artwork

Recao said Tradepak uses Adobe Illustrator equipped with AI to make adjustments on colors, design placement and other elements before printing. 

For artwork, Colgate-Palmolive works with Esko software, which uses automation throughout the packaging go-to-market process. The use of AI in artwork management has improved quality while saving time, Saini said.



Source link

Continue Reading

AI Research

State AGs’ Continued Focus on Enforcement – With or Without AI Legislation — The Good Bot: Artificial Intelligence, Health Care, and the Law | Troutman Pepper Locke

Published

on


In this episode of The Good Bot, Brett Mason is joined by Gene Fishel and Chris Carlson to discuss the latest state laws targeting AI, especially in health care. They break down new legislation in Colorado, Utah, California, and Texas, highlighting differences in scope and enforcement. They also cover how state attorneys general are using consumer protection and anti-discrimination laws to regulate AI, even in states without AI-specific statutes.


Press CTRL+C to copy embed code to clipboard



Source link

Continue Reading

Trending